Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. Lords Mark Industries Ltd — Acquires Renalyx to Expand AI-Driven Dialys…

Lords Mark Industries Ltd — Acquires Renalyx to Expand AI-Driven Dialysis Technology

9 Mar 2026

Add as preferred source
Key Takeaways

Key Takeaway:
Lords Mark Industries’ acquisition of Renalyx marks a strategic expansion into advanced renal care technology, leveraging AI-enabled dialysis solutions and domestic manufacturing capabilities to strengthen its footprint in India’s growing MedTech ecosystem.

Key Takeaway:
Lords Mark Industries’ acquisition of Renalyx marks a strategic expansion into advanced renal care technology, leveraging AI-enabled dialysis solutions and domestic manufacturing capabilities to strengthen its footprint in India’s growing MedTech ecosystem.

Lords Mark Industries

Lords Mark Industries

0.00%

Expert Analysis

Expert Analysis:

  • Lords Mark Industries Ltd has acquired a majority stake (85%) in Bengaluru-based Renalyx Health Systems, strengthening its presence in the medical technology and renal care segment. The acquired company will continue to operate as an independent unit while supporting Lords Mark’s broader healthcare strategy.

  • Renalyx is the developer of India’s first AI-powered and IoT-enabled smart haemodialysis machine (RxT-21), which enables features such as remote monitoring, real-time clinical data access, and integration with telenephrology platforms to enhance dialysis treatment and patient safety.

  • The dialysis technology is expected to be manufactured in collaboration with Bharat Electronics, with Lords Mark having received a manufacturing licence in September 2025, positioning the company to scale indigenous MedTech innovation under the “Make in India” initiative.

Publisher:MSN